Imperial College London

MrHutanAshrafian

Faculty of MedicineDepartment of Surgery & Cancer

Scientific Advisor
 
 
 
//

Contact

 

+44 (0)20 3312 7651h.ashrafian

 
 
//

Location

 

1089Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Summary

Hutan Ashrafian is a Clinical Lecturer in Surgery. His research objectives are to develop innovative and technological strategies to resolve the global healthcare burden of obesity, metabolic syndrome, obesity-related cardiorespiratory disease, musculoskeletal dysfunction and cancer.

His work encompasses clinical and mechanistic studies of metabolic bariatric surgery, complex biostatistical models, networks and evidence synthesis to guide policy decisions, computational physiology and systems medicine, novel health technology assessment and diagnostic accuracy of biomarkers, robotics and artificial intelligence agents in healthcare, ancient history analytics, academic impact & leadership metrics and regenerative strategies including sports-based and bio-inspired bionic therapies.

Publications

Journals

Cartucho J, Shapira D, Ashrafian H, et al., 2020, Multimodal mixed reality visualisation for intraoperative surgical guidance, International Journal of Computer Assisted Radiology and Surgery, ISSN:1861-6410

Goiana-Da-Silva K, Cruz-e-Silva D, Bartlett O, et al., 2020, The ethics of taxing sugar-sweetened beverages to improve public health, Frontiers in Public Health, Vol:8, ISSN:2296-2565

Posthuma LM, Downey C, Visscher MJ, et al., 2020, Remote wireless vital signs monitoring on the ward for early detection of deteriorating patients: A case series, International Journal of Nursing Studies, Vol:104, ISSN:0020-7489

Goiana-da-Silva F, Severo M, Cruz-E-Silva D, et al., 2020, Projected impact of the Portuguese sugar-sweetened beverages tax on obesity incidence across different age groups: a modelling study, Plos Medicine, Vol:17, ISSN:1549-1277, Pages:1-17

Conference

Ruban A, Liu Z, Glaysher M, et al., 2020, One year of duodenal-jejunal bypass liner therapy (Endobarrier (R)) leads to perturbations in the metabolic profile of urine, plasma and stool of obese diabetic patients., 11th Annual Scientific Meeting of the British-Obesity-and-Metabolic-Surgery-Society (BOMSS), SPRINGER, Pages:S10-S10, ISSN:0960-8923

More Publications